miR-423-3p inhibits CTNNBIP1/WNT preventing hyperandrogenic polycystic ovary syndrome
Biology of Reproduction · 2025
DOI: 10.1093/biolre/ioaf116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of Reproduction, 2025. Verfasst von Shanshan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jining Medical University, No. 669 Xueyuan Road, Donggang District, Rizhao, Shandong Province 276826, PR China. Hauptthemen laut MEDLINE: MicroRNAs, Polycystic Ovary Syndrome, Wnt Signaling Pathway, Hyperandrogenism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Outstanding Talent Research Funding of Xuzhou Medical University, Natural Science Research of the Jiangsu Higher Education Institutions of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) lacks the generally accepted diagnostic biomarkers and targeted therapy. Increasing evidence indicates that microRNAs play a crucial role in PCOS. Hereby, we tested the functional implications of a novel MicroRNA (miR-423-3p) as a mediator in the progress of hyperandrogenic PCOS, as well as its potential as a new serum biomarker and therapeutic target for the PCOS. We found significantly decreased miR-423-3p levels in serum, human granulosa cells (hGCs), and follicular fluid of PCOS patients (n = 40) compared to healthy controls (n = 30), and this decrease corroborated in PCOS-like mouse models. The receiver operating characteristic curve analysis for circulating miR-423-3p indicated high diagnostic potential as a biomarker, with an area under the curve of 82%. miR-423-3p influenced hGC (Human ovarian granulosa cell line KGN) proliferation by directly targeting CTNNBIP1-modulated Wingless-type (WNT) signaling pathway. We further proved as mechanistic role that the elevated dihydrotestosterone inhibited the expression of miR-423-3p via the activation of the androgen receptor, and the overexpression of miR-423-3p normalized the function of androgen-induced GCs. While we overexpressed miR-423-3p, it counteracted androgen-induced dysfunction in GCs. Antiandrogen treatment restored the reproductive phenotypes in letrozole-induced PCOS-like mice and regulated miR-423-3p expression and its downstream effects. Ovarian intrabursal injection of miR-423-3p antagomir in wild-type mice induced PCOS-like phenotypes, further underscoring its functional role. Our results demonstrated that miR-423-3p emerged as a novel mediator in hyperandrogenic PCOS progression, and it holds promise as both a diagnostic biomarker and a therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Jining Medical University, No. 669 Xueyuan Road, Donggang District, Rizhao, Shandong Province 276826, PR China.
- State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, No. 2 Yuanmingyuan West Road, Haidian District, Beijing 100193, PR China.
- School of Biomedical Engineering, Tsinghua University, No. 30 Shuangqing Road, Qinghuayuan Subdistrict, Haidian District, Beijing 100084, PR China.
- Department of Physiology, School of Basic Medical Sciences, Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou, Jiangsu Province 221009, PR China.
- National Experimental Teaching Demonstration Center for Basic Medicine, Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou, Jiangsu Province 221009, PR China.
- Department of Biology and Pathology of Human Reproduction, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Władysława Trylińskiego 18, 10-683 Olsztyn, Poland.
ORCID-Profile: Shanshan Zhang, Bing Yao
Förderung
- Outstanding Talent Research Funding of Xuzhou Medical University
- Natural Science Research of the Jiangsu Higher Education Institutions of China
- National Natural Science Foundation of China
- Beijing Natural Science Foundation Program
- National Natural Science Foundation Program
- Shandong Provincial University Youth Innovation Team, China
- Shandong Province Medical Health Science and Technology Project
Zitieren
APA
Zhang, S., Liu, Y., Wang, M., Ponikwicka-Tyszko, D., Wolczynski, S., Chen, L., Huang, X., Yao, B., Rahman, N. A., & Li, X. (2025). miR-423-3p inhibits CTNNBIP1/WNT preventing hyperandrogenic polycystic ovary syndrome. Biology of Reproduction. https://doi.org/10.1093/biolre/ioaf116
Vancouver
Zhang S, Liu Y, Wang M, Ponikwicka-Tyszko D, Wolczynski S, Chen L, et al. miR-423-3p inhibits CTNNBIP1/WNT preventing hyperandrogenic polycystic ovary syndrome. Biology of Reproduction. 2025. doi:10.1093/biolre/ioaf116
BibTeX
@article{Zhang2025,
author = {Zhang, Shanshan and Liu, Yajing and Wang, Mingming and Ponikwicka-Tyszko, Donata and Wolczynski, Slawomir and Chen, Li and Huang, Xuan and Yao, Bing and Rahman, Nafis A and Li, Xiangdong},
title = {miR-423-3p inhibits CTNNBIP1/WNT preventing hyperandrogenic polycystic ovary syndrome},
journal = {Biology of Reproduction},
year = {2025},
doi = {10.1093/biolre/ioaf116}
}
EUVIMED